E-LIB Suche - Ergebnisse für: Réa, D.

1

Real-world Data on Safety Outcome with Treatment of Adjuvan..:

Neralla, H. ; Herring, K. ; Stevens, A...
Clinical Oncology. 36 (2024) 4 - p. e110-e111 , 2024

Link: https://doi.org/10.1016/..

2

Spatial and cumulative organochlorine and mercury exposure ..:

O'Hara, T.M. ; Ylitalo, G.M. ; Crawford, S.G....
Marine Pollution Bulletin. 205 (2024) - p. 116592 , 2024

Link: https://doi.org/10.1016/..

3

142 Elexacaftor-tezacaftor-ivacaftor and spirometry-control..:

Lester, K. ; McNally, P. ; Davies, J....
Journal of Cystic Fibrosis. 22 (2023) - p. S75-S76 , 2023

Link: https://doi.org/10.1016/..

4

N10 Facilitators and inhibitors to first adult care visits ..:

Rea, J ; Greaney, A M ; Farrell, D
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i1045-i1046 , 2023

Link: https://doi.org/10.1093/..

5

140 Rhinosinusitis outcomes in people with cystic fibrosis ..:

Stone, R. ; Lester, K. ; Cox, D....
Journal of Cystic Fibrosis. 22 (2023) - p. S74 , 2023

Link: https://doi.org/10.1016/..

6

Real-world Experience within Standard NHS Use of Traztuzuma..:

Graef, S. ; Kussaibati, R. ; Herring, K....
Clinical Oncology. 35 (2023) 6 - p. e416 , 2023

Link: https://doi.org/10.1016/..

7

Sacubitril-valsartan improves radial and longitudinal strai..:

Quagliariello, V ; Buccolo, S ; Iovine, M...
European Heart Journal - Cardiovascular Imaging. 23 (2022) Supplement_1 - p. , 2022

Link: https://doi.org/10.1093/..

8

P701: COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN..:

Saußele, S. ; Evans, N. ; Nicolini, F. E....
HemaSphere. 6 (2022) - p. 596-597 , 2022

Link: https://doi.org/10.1097/..

9

P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS W..:

Apperley, J. ; Kantarjian, H. ; Deininger, M....
HemaSphere. 6 (2022) - p. 602-603 , 2022

Link: https://doi.org/10.1097/..

10

S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 S..:

Rea, D. ; Hochhaus, A. ; Mauro, M. J....
HemaSphere. 6 (2022) - p. 56-57 , 2022

Link: https://doi.org/10.1097/..

11

P700: TREATMENT-FREE REMISSION (TFR) AFTER DASATINIB IN PAT..:

Shah, N. P. ; García-Gutiérrez, V. ; Jiménez-Velasco, A....
HemaSphere. 6 (2022) - p. 595-596 , 2022

Link: https://doi.org/10.1097/..

12

149 Patterns of Fluoroquinolone Use in the Emergency Depart..:

Tran, Q. ; Rea, J. ; Lankenau, M....
Annals of Emergency Medicine. 80 (2022) 4 - p. S68-S69 , 2022

Link: https://doi.org/10.1016/..

13

Corrigendum to "Regional variations and drivers of mercury ..:

Rea, L.D. ; Castellini, J.M. ; Avery, J.P....
Science of The Total Environment. 831 (2022) - p. 154887 , 2022

Link: https://doi.org/10.1016/..

14

Managing hematological cancer patients during the COVID-19 ..:

Buske, C. ; Dreyling, M. ; Alvarez-Larrán, A....
ESMO Open. 7 (2022) 2 - p. 100403 , 2022

Link: https://doi.org/10.1016/..

15

EE360 Health Care Resource Utilization With Asciminib and B..:

Cortes, JE ; Sasaki, K ; Réa, D...
Value in Health. 25 (2022) 12 - p. S125-S126 , 2022

Link: https://doi.org/10.1016/..